PI Industries shares fell 10% to a 52-week low of ₹1,968.15 following a weak Q2 FY27 financial report. Consolidated net profit dropped 70.1% to ₹122 crore, while EBITDA margins narrowed sharply to 13.7%. Investors are reacting to a significant decline in agrochemical exports, raising concerns about the company's ability to maintain profitability amid global demand weakness.
PI Industries shares saw a sharp decline on November 5, 2026, dropping 10% to reach a 52-week low of ₹1,968.15. This negative market reaction followed the company's Q2 FY27 financial results, which revealed substantial pressure on both top-line revenue and bottom-line profitability.
The company reported a consolidated net profit of ₹122 crore for the second quarter, marking a 70.1% decline compared to the same period in the previous year. Revenue also softened, falling 9.1% to ₹1,702 crore. Perhaps the most concerning figure for investors was the sharp contraction in EBITDA margins—a key measure of operating efficiency—which fell to 13.7% from 28.9% in the same quarter last year. This indicates that the company is facing difficulty in maintaining its profitability levels amid changing market conditions.
The primary driver behind this performance was weakness in the core agrochemical export business, which experienced an 18% decline in revenue. PI Industries, which has historically relied on its agrochemical segment for a large portion of its earnings, is currently navigating a period of subdued global demand and inventory cycles that are affecting shipment volumes and pricing power. While the company's other segments, such as pharmaceuticals and biologicals, reported growth during the quarter, their contribution was not large enough to offset the impact of the slowdown in the primary agrochemical business.
From an investor standpoint, the core issue remains margin sustainability. The sharp drop in EBITDA margins suggests the company is struggling with higher input costs and may not be able to fully pass these costs on to customers, or is experiencing pricing pressure due to global competition. This margin compression has historically been a significant monitorable for shareholders in the specialty chemicals sector.
The path ahead for PI Industries will likely depend on whether global demand for agrochemicals shows signs of recovery in the second half of the fiscal year. Investors will be closely watching management commentary regarding the sustainability of the current margins and whether the growth in the pharmaceutical and biologicals divisions can accelerate to provide a better cushion against volatility in the agrochemical market. Until clear signs of operational recovery appear, the stock may continue to face pressure from investors who are closely reviewing the company's growth prospects.